Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
1.
Article in English | WPRIM (Western Pacific) | ID: wpr-773398

ABSTRACT

OBJECTIVE@#Identification of new risk factors is needed to improve prediction of adverse outcomes in patients with three-vessel disease (TVD). The present study aimed to evaluate the prognostic values of serum chloride and sodium levels in patients with TVD.@*METHODS@#We used data from a prospective cohort of consecutive patients with angiographically confirmed TVD. The primary endpoint was all-cause death. Cox proportional hazard regression was used to analyze the relationship of serum chloride and sodium levels with long-term outcomes of TVD patients.@*RESULTS@#A total of 8,318 participants with available serum chloride and sodium data were included in this analysis. At baseline, patients in the low tertiles group of serum chloride level (⪕ 102.0 mmol/L) or serum sodium level (⪕ 139.0 mmol/L) had more severe disease conditions. During a median follow-up of 7.5-year, both low serum chloride level and low serum sodium level were found to be associated with an increased risk for mortality in univariate analysis. However, when both parameters were incorporated into a multivariate model, only low serum sodium level remained to be an independent predictor of all-cause death (hazard ratio: 1.16, 95% confidence interval: 1.01-1.34, P = 0.041). Modest but significant improvement of discrimination was observed after incorporating serum sodium level into the Synergy between percutaneous coronary intervention (PCI) with Taxus and Cardiac Surgery score.@*CONCLUSION@#Serum sodium level is more strongly associated with long-term outcomes of TVD patients compared with serum chloride level. Low serum sodium level is an independent risk factor for mortality, but only provides modest prognostic information beyond an established risk model.


Subject(s)
Aged , Female , Humans , Male , Middle Aged , China , Epidemiology , Chlorides , Blood , Coronary Artery Disease , Blood , Diagnosis , Mortality , Prognosis , Prospective Studies , Sodium , Blood
2.
Chinese Medical Journal ; (24): 1-9, 2018.
Article in English | WPRIM (Western Pacific) | ID: wpr-324693

ABSTRACT

<p><b>BACKGROUND</b>Patients with premature triple-vessel disease (PTVD) have a higher risk of recurrent coronary events and repeat revascularization; however, the long-term outcome of coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), and medical therapy (MT) alone for PTVD patients is controversial. The aim of this study is to evaluate the long-term outcome of PTVD patients among these three treatment strategies, to find out the most appropriate treatment methods for these patients.</p><p><b>METHODS</b>One thousand seven hundred and ninety-two patients with PTVD (age: men ≤50 years and women ≤60 years) were enrolled between 2004 and 2011. The primary end point was all-cause death. The secondary end points were cardiac death, myocardial infarction, stroke, or repeat revascularization.</p><p><b>RESULTS</b>PCI, CABG, and MT alone were performed in 933 (52.1%), 459 (25.6%), and 400 (22.3%) patients. Both PCI and CABG were associated with lower all-cause death (4.6% vs. 4.1% vs. 15.5%, respectively, P < 0.01) and cardiac death (2.8% vs. 2.0% vs. 9.8%, respectively, P < 0.01) versus MT alone. The rate of repeat revascularization in the CABG group was significantly lower than those in the PCI and MT groups. After adjusting for baseline factors, PCI and CABG were still associated with similar lower risk of all-cause death and cardiac death versus MT alone (all-cause death: hazard ratio [HR]: 0.35, 95% confidence interval [CI]: 0.23-0.53, P < 0.01 and HR: 0.35, 95% CI: 0.18-0.70, P = 0.003, respectively, and cardiac death: HR: 0.32, 95% CI: 0.19-0.54, P < 0.01 and HR: 0.36, 95% CI: 0.14-0.93, P = 0.03, respectively).</p><p><b>CONCLUSIONS</b>PCI and CABG provided equal long-term benefits for all-cause death and cardiac death for PTVD patients. Patients undergoing MT alone had the worst long-term clinical outcomes.</p><p><b>TRIAL REGISTRATION</b>ClinicalTrials.gov; Identifier: NCT02634086. https://www.clinicaltrials.gov/ct2/show/record/NCT02634086?term=NCT02634086&rank=1.</p>

3.
J Biomed Mater Res A ; 84(3): 761-8, 2008 Mar 01.
Article in English | MEDLINE | ID: mdl-17635009

ABSTRACT

By sol-gel processing, the regenerated nano-TiO(2)/SF (silk fibroin) hybrid films were synthesized using different ratios of TiO(2) to SF. The experimental results revealed that the nano-TiO(2) particles were well dispersed in the regenerated SF. The diameter of the nano-TiO(2) particles processed by sol-gel method was about 80 nm. Through Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), X-ray energy dispersive spectrometer (EDS), Thermogravimetric analysis (TGA), and Derivative thermogravimetry (DTG), the structures and properties of these hybrid films were characterized. The XRD measurement indicated that the crystal structures of the hybrid films were transited from typical Silk I to typical Silk II. However, it was found that excessive increase in the content of nano-TiO(2) led to the breakage of the crystal structures of the hybrid films. The FTIR and EDS analysis showed that new bonds were formed between the nano-TiO(2) particles and the SF. Through TGA and DTG, it was demonstrated that the heat transition temperature of the hybrid films was also enhanced.


Subject(s)
Biocompatible Materials , Fibroins , Gels , Nanoparticles , Phase Transition , Titanium , Animals , Biocompatible Materials/chemical synthesis , Biocompatible Materials/chemistry , Fibroins/chemistry , Solutions , Titanium/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...